Department of Urology Skåne University Hospital, Malmö, and Institution of Translational Medicine, Lund University, Malmö, Sweden.
Scand J Urol. 2024 Jun 19;59:131-136. doi: 10.2340/sju.v59.25973.
Disease recurrence, particularly intravesical recurrence (IVR) after radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC), is common. We investigated whether violations of onco-surgical principles before or during RNU, collectively referred to as surgical violation (SV), were associated with survival outcomes. Material and methods: Data from a consecutive series of patients who underwent RNU for UTUC 2001-2012 at Skåne University Hospital Lund/Malmö were collected. Preoperative insertion of a nephrostomy tube, opening the urinary tract during surgery or refraining from excising the distal ureter were considered as SVs. Survival outcomes in patients with and without SV (IVR-free [IVRFS], disease-specific [DSS] and overall survival [OS]) were assessed using multivariate Cox regression analyses (adjusted for tumour stage group, prior or concomitant bladder cancer, comorbidity and preoperative urinary cytology).
Of 150 patients, 47 (31%) were subjected to at least one SV. Overall, SV was not associated with IVRFS (HR 0.81, 95% CI 0.4-1.6) but with worse DSS (HR 1.9, 95% CI 1.03-3.7) and OS (HR 1.9, 95% CI 1.2-3) in multivariable analysis. Additional analyses with a broader definition of SV including also preoperative instrumentation of the upper urinary tract (ureteroscopy and/or double J stenting) showed similar outcomes for DSS (HR 2.1, 95% CI 1.1-4.3).
Worse survival outcomes, despite no difference in IVR, for patients that were subjected to the violation of sound onco-surgical principles before or during RNU for UTUC strengthen the notion that adhering to such principles is a cornerstone in upper tract urothelial cancer surgery.
上尿路上皮癌(UTUC)患者行根治性肾输尿管切除术(RNU)后,疾病复发,尤其是膀胱内复发(IVR)较为常见。我们研究了在 RNU 术前或术时是否存在违反肿瘤外科原则的情况,将这些情况统称为手术侵犯(SV),其是否与生存结果相关。
本研究收集了 2001 年至 2012 年期间在隆德/马尔默斯科讷大学医院接受 RNU 治疗的 UTUC 连续患者的数据。术前放置肾造瘘管、术中打开尿路或不切除远端输尿管被视为 SV。使用多变量 Cox 回归分析(根据肿瘤分期、既往或同时性膀胱癌、合并症和术前尿细胞学检查进行调整)评估 SV 患者(无 IVRFS、疾病特异性 [DSS] 和总体生存 [OS])的生存结果。
在 150 例患者中,47 例(31%)至少存在 1 种 SV。总体而言,SV 与 IVRFS 无关(HR 0.81,95%CI 0.4-1.6),但与 DSS(HR 1.9,95%CI 1.03-3.7)和 OS(HR 1.9,95%CI 1.2-3)更差有关,多变量分析结果一致。采用更广泛的 SV 定义(包括上尿路术前检查[输尿管镜检查和/或双 J 支架置入])的附加分析结果显示,DSS 的结果相似(HR 2.1,95%CI 1.1-4.3)。
尽管 IVR 无差异,但在 RNU 术前或术时违反合理的肿瘤外科原则的患者的生存结果更差,这进一步证实了遵守这些原则是上尿路上皮癌手术的基石。